# Oral Sulopenem Versus Amoxicillin/Clavulanate for Uncomplicated Urinary Tract Infection in Adult Women

> **NCT05584657** · PHASE3 · COMPLETED · sponsor: **Iterum Therapeutics, International Limited** · enrollment: 2229 (actual)

## Conditions studied

- Urinary Tract Infections
- Cystitis

## Interventions

- **DRUG:** Sulopenem etzadroxil/probenecid
- **DRUG:** Amoxicillin/clavulanate

## Key facts

- **NCT ID:** NCT05584657
- **Lead sponsor:** Iterum Therapeutics, International Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-18
- **Primary completion:** 2023-11-03
- **Final completion:** 2023-11-21
- **Target enrollment:** 2229 (ACTUAL)
- **Last updated:** 2024-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05584657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05584657, "Oral Sulopenem Versus Amoxicillin/Clavulanate for Uncomplicated Urinary Tract Infection in Adult Women". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05584657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*